CIK 0001723128
- Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-27 | Branning Todd P. SVP and CFO | Grant or award · Restricted Stock Units | +83,113 | 83,113 | ||
| 2020-02-27 | Branning Todd P. SVP and CFO | Grant or award · Performance-Based Restricted Stock Units | +166,226 | 166,226 | ||
| 2020-01-22 | Branning Todd P. SVP and CFO | Option exercise | +20,096 | 20,096 | ||
| 2020-01-22 | Branning Todd P. SVP and CFO | Shares withheld for taxes | −7,311 | $5.13 | $38K | 12,785 |
| 2020-01-22 | Branning Todd P. SVP and CFO | Option exercise · Restricted Stock Units | −20,096 | 60,290 | ||
| 2019-11-13 | Branning Todd P. SVP, Chief Financial Officer | Returned to the company · Stock Option | −163,666 | 0 | ||
| 2019-11-13 | Branning Todd P. SVP, Chief Financial Officer | Grant or award · Stock Option | +163,666 | 163,666 | ||
| 2019-01-22 | Branning Todd P. SVP, Chief Financial Officer | Grant or award · Stock Option | +163,666 | 163,666 | ||
| 2019-01-22 | Branning Todd P. SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +80,386 | 80,386 |
Page 1 of 1 · 9 trades